Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1990;10:1-7

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Minno, G.
Right arrow Articles by Mancini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Minno, G.
Right arrow Articles by Mancini, M.

Arteriosclerosis, Vol 10, 1-7, Copyright © 1990 by American Heart Association


ARTICLES

Measuring plasma fibrinogen to predict stroke and myocardial infarction

G Di Minno and M Mancini
Istituto di Medicina Interna e Malattie Dismetaboliche, Universita degli Studi di Napoli, Italy.

Epidemiological observations indicate that high plasma fibrinogen levels are strongly correlated with the frequency of two major thrombotic complications of atherosclerosis, stroke and myocardial infarction. Thrombosis is increasingly recognized as a central mechanism in stroke and myocardial infarction, and fibrinogen is involved in events thought to play a major role in thrombosis. Therefore, elucidation of the relationship between fibrinogen and thrombosis may strengthen the predictive value of this protein and suggest new treatment to prevent stroke and myocardial infarction. The current data relating fibrinogen to thrombosis are not easy to reconcile with the available epidemiological observations. In addition, advances in understanding the atherogenic potential of several risk factors for coronary heart disease have used information on the measurement of the risk factors in population-based studies. Thus, measuring plasma fibrinogen to predict stroke and myocardial infarction may be important in gaining insight into the thrombogenic potential of this protein and in inspiring new strategies against the thrombotic complications of atherosclerosis.


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Aono, T. Ohkubo, M. Kikuya, A. Hara, T. Kondo, T. Obara, H. Metoki, R. Inoue, K. Asayama, Y. Shintani, et al.
Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions: The Ohasama Study
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 963 - 968.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Feinbloom and K. A. Bauer
Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2043 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Kang, K. Chu, and J.-K. Roh
POEMS Syndrome, Fibrinogen, and Ischemic Stroke: A Critical Point of View--Reply
Arch Neurol, January 1, 2004; 61(1): 155 - 156.
[Full Text] [PDF]


Home page
JAMAHome page
D. G. Hackam and S. S. Anand
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
JAMA, August 20, 2003; 290(7): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Kang, K. Chu, D.-E. Kim, S.-W. Jeong, J.-W. Lee, and J.-K. Roh
POEMS Syndrome Associated With Ischemic Stroke
Arch Neurol, May 1, 2003; 60(5): 745 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
K G M Moons, M L Bots, J T Salonen, P C Elwood, A Freire de Concalves, Y Nikitin, J Sivenius, D Inzitari, V Benetou, J Tuomilehto, et al.
Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?
J Epidemiol Community Health, February 1, 2002; 56(90001): i30 - 36.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
O. Parra
Sleep-disordered breathing and stroke: is there a rationale for treatment?
Eur. Respir. J., October 1, 2001; 18(4): 619 - 622.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. S. M. Shamsuzzaman and V. K. Somers
Fibrinogen, Stroke, and Obstructive Sleep Apnea . An Evolving Paradigm of Cardiovascular Risk
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2018 - 2020.
[Full Text]


Home page
BloodHome page
M. Margaglione, R. Santacroce, D. Colaizzo, D. Seripa, G. Vecchione, M. R. Lupone, D. De Lucia, P. Fortina, E. Grandone, C. Perricone, et al.
A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing
Blood, October 1, 2000; 96(7): 2501 - 2505.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1368 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Kessler, C. Spitzer, D. Stauske, S. Mende, J. Stadlmuller, R. Walther, and R. Rettig
The Apolipoprotein E and ß-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2880 - 2884.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
A. Kaplan, S. Kaplan, K. F. Marcoe, L. R. Sauvage, and W. P. Hammond
Identification of Potential Predisposition to Clinical Atherosclerosis: A Clinical Concept Based on Integration of Significant Blood Parameters with Platelet Aggregation Scores
Clinical and Applied Thrombosis/Hemostasis, July 1, 1997; 3(3): 174 - 182.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. E. Montgomery, P. Clarkson, O.M. Nwose, D.P. Mikailidis, I.A. Jagroop, C. Dollery, J. Moult, F. Benhizia, J. Deanfield, M. Jubb, et al.
The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G-453-A Polymorphism of the ß-Fibrinogen Gene
Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 386 - 391.
[Abstract] [Full Text]